AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo

Submitted by admin on July 27, 2020 - 11:00am
Source: 
Pharmaforum
News Tags: 
AstraZeneca
Daiichi Sankyo
DS-1062
antibodies
cancer
Headline: 
AstraZeneca inks $6bn cancer drug deal with Daiichi Sankyo
snippet: 

AstraZeneca has begun a new agreement with Daiichi Sankyo to develop and market an antibody to treat cancer, worth up to $6 billion.

Do Not Allow Advertisers to Use My Personal information